Affiliation:
1. University of Kragujevac , Serbia , Faculty of Medical Sciences, Department of Nuclear medicine
Abstract
Abstract
Circulating thyroglobulin measurements is a highly specific test in the management of patients affected by differentiated thyroid cancer after total thyroidectomy, followed by radioiodine ablation. The aim of our study was to compare two thyroglobulinimmunoradiometric assays (INEP, Serbia and Cisbio Bioassays, France). Study included 42 patients of both genders with DTC. The subjects were on suppres¬sive doses of levothyroxine and followed up. Results showed concordance between the two assay methods for determining serum thyroglobulin for 39 (92.85%) patients. Statistical analysis showed that there was a direct correlation between two IRMA tests, with a positive correlation coefficient r=0.613 (p 0.05). We concluded that there is good agreement between the two thyroglobulin assays compared in this study.
Reference20 articles.
1. 1. Cooper DS, Doherty GM, Haugen BR, et al. (2009). Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19:1167–1214.
2. 2. Pacini F, Schlumberger M, Dralle H, et al. (2006). European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol, 154:787–803.
3. 3. Feldt-Rasmussen U, Profilis C, Colinet E, et al. (1996). Human thyroglobulin reference material (CRM 457). 1st part: assessment of homogeneity, stability and immunoreactivity. Annales de Biologie Clinique Paris, 54:337–342.
4. 4. Stanojevic M, Savin S, Cvejic D, et al. (2009). Correlation of thyroglobulin concentrations measured by radioimmunoassay and immunometric assay and the influence of thyroglobulin antibody. J Immunoassay Immunochem, 30:197-207.
5. 5. Stanojevic M, Savin S, Cvejic D, et al. (2009). Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients. J Clin Lab Anal, 23:341-346.